Training in flexible intensive insulin therapy improves quality of life, decreases the risk of hypoglycaemia and ameliorates poor metabolic control in patients with type 1 diabetes

Diabetes Research and Clinical Practice
C Falconnier BendikJ Puder

Abstract

Intensified insulin therapy has evolved to be the standard treatment of type 1 diabetes. However, it has been reported to increase significantly the risk of hypoglycaemia. We studied the effect of structured group teaching courses in flexible insulin therapy (FIT) on psychological and metabolic parameters in patients with type 1 diabetes. We prospectively followed 45 type 1 diabetic patients of our outpatient clinic participating in 5 consecutive FIT teaching courses at the University Hospital of Basel. These courses consist of 7 weekly ambulatory evening group sessions. Patients were studied before and 1, 6, and 18 months after the course. Main outcome measures were glycated haemoglobin (HbA1c), severe hypoglycaemic events, quality of life (DQoL), diabetes self-control (IPC-9) and diabetes knowledge (DWT). Quality of life, self-control and diabetes knowledge improved after the FIT courses (all p<0.001). The frequency of severe hypoglycaemic events decreased ten-fold from 0.33 episodes/6 months at baseline to 0.03 episodes/6 months after 18 months (p<0.05). Baseline HbA1c was 7.2+/-1.1% and decreased in the subgroup with HbA1c > or = 8% from 8.4% to 7.8% (p<0.05). In an unselected, but relatively well-controlled population of t...Continue Reading

References

Jun 1, 1995·Journal of Internal Medicine·I MühlhauserM Berger
May 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·U BottM Berger
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Aug 1, 1997·Diabetologia·S BottI Mühlhauser
Oct 4, 2005·Current Medical Research and Opinion·Ruth E DavisCraig J Currie

❮ Previous
Next ❯

Citations

Oct 19, 2011·Journal of General Internal Medicine·Kelly Marvin JeppesenWilliam F Miser
Oct 18, 2012·The Diabetes Educator·Carolyn T ThorpeEdwin B Fisher
Feb 4, 2014·Canadian Journal of Diabetes·Catherine LerouxRémi Rabasa-Lhoret
Jun 4, 2013·Diabetes Research and Clinical Practice·Anna Elisabeth MinderHenryk Zulewski
Dec 3, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·D Gunn, P Mansell
Apr 13, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·D AlbrechtH Zulewski
Mar 25, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·S SchmidtK Nørgaard
Jun 12, 2020·Nigerian Journal of Clinical Practice·N Ozdemir, A Z Sahin
Jun 10, 2010·The Medical Journal of Australia·H David McIntyreKristen S Gilshenan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.